Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure

  1. Blanco, F.J.
  2. Rubio-Romero, E.
  3. Sanmartí, R.
  4. Díaz-Torné, C.
  5. Talavera, P.
  6. Dunkel, J.
  7. Naredo, E.
Journal:
Reumatologia Clinica

ISSN: 1885-1398 1699-258X

Year of publication: 2020

Volume: 16

Issue: 5

Pages: 345-352

Type: Article

DOI: 10.1016/J.REUMA.2018.07.009 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals